Search results

Evidence-based recommendations on panobinostat (Farydak) for treating multiple myeloma after at least 2 previous treatments.

Result type

Technology appraisal guidance

Published

27 January 2016

Evidence-based recommendations on omalizumab (Xolair) for treating severe chronic spontaneous urticaria in people of 12 and over.

Result type

Technology appraisal guidance

Published

8 June 2015

Home What NICE does Digital health...

Evidence-based recommendations on testing for epidermal growth factor receptor tyrosine kinase (EGFR–TK) mutations in untreated, locally advanced or metastatic non-small-cell-lung cancer.

Result type

HealthTech guidance

Published

14 August 2013

Providing an advisory service for international health organisations, ministries and government agencies whose task is to improve evidence-based decision making in health and social care

of focal and generalised seizures since publication of the original NICE guideline on epilepsy in 2004 have not been...

Result type

Research recommendation

Published

13 August 2021

NICE has developed a medtech innovation briefing (MIB) on Peptest for diagnosing gastro-oesophageal reflux

Result type

Medtech innovation briefing

Published

22 May 2015

Early value assessment (EVA) guidance on artificial intelligence (AI) technologies to aid contouring for radiotherapy treatment planning in people having external beam radiotherapy.

Result type

HealthTech guidance

Published

27 September 2023

NICE has developed a medtech innovation briefing (MIB) on Aquablation robotic therapy for lower urinary tract symptoms caused by benign prostatic hyperplasia .

Result type

Medtech innovation briefing

Published

31 January 2023

How to register with us as a diagnostic technologies stakeholder.

How to register with us as a diagnostic technologies stakeholder.

Evidence-based recommendations on ribociclib (Kisqali) for treating hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in adults who have had previous endocrine therapy.

Result type

Technology appraisal guidance

Published

31 March 2021

Evidence-based recommendations on carmustine implants (Gliadel) and temozolomide for treating newly diagnosed high-grade glioma in adults.

Result type

Technology appraisal guidance

Published

27 June 2007

Summary of the evidence on oxybutynin for treating hyperhidrosis (excessive sweating) to inform local NHS planning and decision-making

Result type

Evidence summary

Published

21 March 2017

NICE has developed a medtech innovation briefing (MIB) on OrganOx metra for liver transplant .

Result type

Medtech innovation briefing

Published

14 September 2021